+ 2.69
+ 1.88%

Challenges, Concerns Surround Rise In Automated Cannabis Cultivation

August 5, 2019 2:50 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Challenges, Concerns Surround Rise In Automated Cannabis Cultivation

During the July 31 Democratic presidential debate, candidate Andrew Yang doubled down on his concerns about the effect of automation on American jobs.

Those same concerns are spreading in the cannabis industry. 

Some experts and consumers are eyeing automation’s impact on the plant and the cultivation process.

A sharp change has occurred in a short period of time, said Chelsey Moter, the founder and CEO of the cannabis growth marketing company Cannack. 

"I remember when I first went to MJBizCon two years ago and saw this nice family-owned business who made trimming scissors to make manual labor more productive. Then last year, I see industrial-scale trimming machines that completely eliminate the need of a physical human," she said. 

Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more!

Moter also acknowledged the reasons for going with an automated process, including cost effectiveness. 

Jill Ellsworth is CEO of Willow Industries, a company specializing in post-harvest microbial decontamination.

Ellsworth sees automation as a "huge step toward more legitimacy" in the cannabis industry.

"When SOPs become automated, that is when we know the industry is growing and achieving market share."

Automation does create additional challenges, Ellsworth said, singling out cross-contamination prevention at facilities as an example.

For Natura, a cannabis cultivation, manufacturing and distribution platform, the approach to automation revolves around value proposition, said CEO Craig Powell. 

"Automation is that vehicle; allowing us to make changes quickly, efficiently and even remotely. The net result is [an] improvement in yield, enhanced quality or, sometimes even more important, risk mitigation."

Oher areas that benefit from automation include the enaction of best practices, increasing utilization and decreasing manpower requirements, he said.  

Both Ellsworth and Powell see automation increasing as the industry further develops.

Concerns from consumers, enthusiasts and experts do exist.

The Human Touch 

Moter voiced concerns about "overly processed" cannabis made by machinery, resulting in a decline in taste and experience.

High Times senior Cultivation Editor and cannabis author Danny Danko said larger grow operations rely on automation, and some sites he visited have reached the point where very few human hands touch the plant at all.

The process has benefits that include a reduction in contamination from humans, insects and other factors, he said. 

Yet "without that human touch, something in the product is lacking," Danko said. 

The cultivation expert said the best cannabis comes from a hand-grown, sun-grown process. The additional steps that are required are hand trimming, proper curing and not overfeeding the plant — a mistake he said most cultivators make.

In the end, Danko said there will be space for both methods in the market.

“I think the automation is going to be the way that the industrial cannabis is created, mostly for the production of concentrates and things like that. And the craft flower industry is going to stick with human contact on the plants.”

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Related Articles

The Week In Cannabis: Federal Drug Decrim, Connecticut, Louisiana, Big M&A Moves And More

U.S. House Reps Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO), in collaboration with the Drug Policy Alliance, introduced the Drug Policy Reform Act (DPRA): a bill seeking to end criminal penalties for drugs possession at the federal level. read more

The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More

As we near the end of the first half of 2021, we can see cannabis stocks traded mostly up by double digits, with the Amplify Seymour Cannabis ETF (NYSE: CNBS) delivering gains of more than 50% year-to-date. This week, however, stocks posted mixed performances. read more

Pennsylvania's Cannabis Market: What Investors And Entrepreneurs Need To Know

Pennsylvania's medical cannabis market has been one of the better success stories in the industry to date. read more

Missouri's Cannabis Market: What Investors And Entrepreneurs Need To Know

Missouri often gets lost in the shuffle when discussing U.S. cannabis. Those ignoring the Show-Me State and its medical market may be missing an early opportunity as an investor or entrepreneur. read more